CompletedPhase 2

Effectiveness of Zinc Supplementation With Topical Retinoids in Acne Vulgaris Patients

Bangladesh122 participantsStarted 2021-04-27

Plain-language summary

The study was 8 weeks, randomized, double-blind, placebo-controlled trial to assess the effect of zinc sulphate on symptoms of mild and moderate acne vulgaris in 122 patients. Participants was assessed at baseline, and 8 weeks. Subjects was randomized to receive either 20 mg elemental zinc daily or 20 mg placebo tablet daily for 8 weeks. The primary outcome was the measure of the GAGS score and the secondary measure includes serum zinc level and evaluate adverse effects.

Who can participate

Age range11 Years – 35 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Newly diagnosed mild and moderate AV patients diagnosed by a dermatologist at the outpatient Department of Dermatology and Venereology, * Age: 11-35 years, * Gender: Both male and female Exclusion Criteria: * Pregnancy and lactation, * History of oral contraceptive pills, zinc, and iron intake, * Suffering from any cosmetic induced acne

What they're measuring

Acne vulgaris severity score assessment

Timeframe: 8 weeks

Trial details

NCT IDNCT04899843

SponsorBangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-11-30

View on ClinicalTrials.gov More Acne Vulgaris trials